Filtered By:
Condition: Hives
This page shows you your search results in order of date. This is page number 4.
Order by Relevance | Date
Total 3976 results found since Jan 2013.
Allergic Reactions to E. coli Asparaginase are Associated with Decreased Asparaginase Activity in an Indonesian Pediatric Population with ALL
CONCLUSION: The E. coli ASP activity with adequate levels were significantly higher in non-allergy group. Its activity level was not accompanied by increment of IgG in allergic group indicates other factors might affect activity levels in allergy group.PMID:37642064 | DOI:10.31557/APJCP.2023.24.8.2773
Source: Asian Pacific Journal of Cancer Prevention - August 29, 2023 Category: Cancer & Oncology Authors: Nur Melani Sari Afiat Berbudi Susi Susanah Lelani Reniarti Eddy Supriyadi Gertjan J L Kaspers Randal K Buddington Scott Howard Ponpon Idjradinata Source Type: research
Cyclosporine for omalizumab-refractory chronic urticaria: a report of five cases
While both the AAAAI/ACAAI and the EAACI/GA2LEN/EuroGuiDerm/APAAACI guidelines recommend starting cyclosporine for patients with chronic urticaria who have had an inadequate response to omalizumab, many clinician...
Source: Allergy, Asthma and Clinical Immunology - August 29, 2023 Category: Allergy & Immunology Authors: Anthony F. LaCava and Olajumoke O. Fadugba Tags: Case report Source Type: research
Alpha ‐gal syndrome—Food or drug allergy: A case report
We present a patient with recurrent urticaria and suspected repaglinide hypersensitivity, who was eventually diagnosed with alpha-gal syndrome, wanting to emphasize possible drug allergy misdiagnosis and required caution with the medication choice.
Source: Clinical Case Reports - August 24, 2023 Category: General Medicine Authors: Marina Bo žan,
Vesna Vukičević Lazarević,
Ivan Marković,
Jadranka Morović‐Vergles,
Joško Mitrović Tags: CASE REPORT Source Type: research
Urticaria Exacerbations and Adverse Reactions in Patients with Chronic Urticaria Receiving COVID-19 Vaccination: Results of the UCARE COVAC-CU Study
Source: Journal of Allergy and Clinical Immunology - August 11, 2023 Category: Allergy & Immunology Authors: Emek Kocaturk, Pascale Salameh, Esra Sarac, Carolina E. Vera Ayala, Simon Francis Thomsen, Torsten Zuberbier, Luis Felipe Ensina, Todor A. Popov, Martijn van Doorn, Ana Maria Gim énez-Arnau, Riccardo Asero, Paulo Ricardo Criado, Clive Grattan, Niall Conl Source Type: research
Recall Urticaria with Infusion of Agalsidase Beta
Ann Allergy Asthma Immunol. 2023 Aug 7:S1081-1206(23)00563-X. doi: 10.1016/j.anai.2023.08.001. Online ahead of print.NO ABSTRACTPMID:37557952 | DOI:10.1016/j.anai.2023.08.001
Source: Annals of Allergy, Asthma and Immunology - August 9, 2023 Category: Allergy & Immunology Authors: Raagini Suresh Yedidi Jonathan A Bernstein Source Type: research
Molecules, Vol. 28, Pages 5979: Malondialdehyde as a Potential Oxidative Stress Marker for Allergy-Oriented Diseases: An Update
a Minciullo
Malondialdehyde (MDA) is a compound that is derived from the peroxidation of polyunsaturated fatty acids. It has been used as a biomarker to measure oxidative stress in various biological samples in patients who are affected by a wide range of diseases. The aim of our work is to provide an updated overview of the role of MDA as a marker of oxidative stress in allergy-related diseases. We considered studies involving both paediatric and adult patients affected by rhinitis, asthma, urticaria and atopic dermatitis. The measurement of MDA was performed on different types of samples. The reported data highlight ...
Source: Molecules - August 9, 2023 Category: Chemistry Authors: Raffaele Cordiano Mario Di Gioacchino Rocco Mangifesta Claudia Panzera Sebastiano Gangemi Paola Lucia Minciullo Tags: Review Source Type: research
Recall Urticaria with Infusion of Agalsidase Beta
No funding was received for this work.
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Raagini Suresh Yedidi, Jonathan A. Bernstein Tags: Letters Source Type: research
